×
About 2,320 results

ALLMedicine™ Heparin-induced Thrombocytopenia Center

Research & Reviews  799 results

Nafamostat Mesilate for Anticoagulation During CRRT in Critically Ill Patients
https://clinicaltrials.gov/ct2/show/NCT05382078

May 19th, 2022 - CRRT, the continuous renal replacement therapy, is widely applied in the field of intensive care medicine. This technology is known as an alternative therapy to save injured kidney with advantages of the accurate volume control, stable acid-alkali...

Cardiovascular and Hematologic Complications of COVID-19 Vaccines.
https://doi.org/10.1097/CRD.0000000000000457
Cardiology in Review; Herblum J, Frishman W

May 17th, 2022 - COVID-19 is a pro-thrombotic and cardiac-damaging disease. There are four vaccines against COVID-19 currently approved in North America, including the mRNA vaccines by Pfizer and Moderna, and the adenovirus vector vaccines by Johnson and Johnson a...

Thrombosis and coagulopathy in COVID-19 patients rceiving ECMO: A narrative review of c...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969294
Journal of Cardiothoracic and Vascular Anesthesia; Yusuff H, Zochios V et. al.

May 17th, 2022 - Extracorporeal membrane oxygenation (ECMO) is an established part of the treatment algorithm for coronavirus disease 2019 (COVID-19)-related acute respiratory distress syndrome. An intense inflammatory response may cause an imbalance in the coagul...

Monoclonal and oligoclonal anti-Platelet Factor 4 antibodies mediate VITT.
https://doi.org/10.1182/blood.2021014588
Blood Kanack A, Bayas A et. al.

May 14th, 2022 - COVID-19 vaccines have been associated with a rare life-threatening thrombotic and thrombocytopenic adverse reaction, vaccine-induced immune thrombotic thrombocytopenia (VITT) characterized by high levels of platelet-activating anti-platelet facto...

Heparin-Induced Thrombocytopenia in Patients With Mechanical Circulatory Support.
https://doi.org/10.1053/j.jvca.2022.03.043
Journal of Cardiothoracic and Vascular Anesthesia; Bolliger D, Santer D et. al.

May 11th, 2022 - Heparin-Induced Thrombocytopenia in Patients With Mechanical Circulatory Support.|2022|Bolliger D,Santer D,Tanaka KA,|

see more →

Guidelines  2 results

American Society of Hematology 2018 guidelines for management of venous thromboembolism...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258919
Blood Advances; Cuker A, Arepally GM et. al.

Nov 30th, 2018 - Heparin-induced thrombocytopenia (HIT) is an adverse drug reaction mediated by platelet-activating antibodies that target complexes of platelet factor 4 and heparin. Patients are at markedly increased risk of thromboembolism. These evidence-based ...

Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest...
https://doi.org/10.1378/chest.08-0677
Chest Warkentin TE, Greinacher A et. al.

Jul 24th, 2008 - This chapter about the recognition, treatment, and prevention of heparin-induced thrombocytopenia (HIT) is part of the Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th E...

see more →

Drugs  45 results see all →

Clinicaltrials.gov  20 results

Nafamostat Mesilate for Anticoagulation During CRRT in Critically Ill Patients
https://clinicaltrials.gov/ct2/show/NCT05382078

May 19th, 2022 - CRRT, the continuous renal replacement therapy, is widely applied in the field of intensive care medicine. This technology is known as an alternative therapy to save injured kidney with advantages of the accurate volume control, stable acid-alkali...

Hydroxychloroquine in Unexplained Recurrent Pregnancy Loss
https://clinicaltrials.gov/ct2/show/NCT05237843

Feb 14th, 2022 - Recurrent pregnancy loss (RPL) remains a significant challenge in obstetrical practice. It is not only emotionally devastating for expectant women but is also medically challenging. Approximately 1-3% of women have recurrent spontaneous abortion, ...

Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters
https://clinicaltrials.gov/ct2/show/NCT04066764

Sep 13th, 2021 - Deep vein thrombosis (DVT) of lower extremities is a venous reflux disorder caused by abnormal coagulation of deep vein blood. The main adverse consequences of DVT are pulmonary embolism (PE) and post-thrombotic syndrome, which can significantly a...

Pregnancy and Risk of Venous Thromboembolism
https://clinicaltrials.gov/ct2/show/NCT03659708

Jan 26th, 2021 - The management of venous thromboembolism (VTE) risk in pregnancy still remains a challenge. An individual assessment of the VTE risk is crucial for optimal thromboprophylaxis, but there is no validated tool to help clinicians stratify the risk in ...

Citrate-based Regional Anticoagulation Versus Heparin for Continuous Renal Replacement Therapy
https://clinicaltrials.gov/ct2/show/NCT01269112

Aug 14th, 2019 - monocentric prospective open-label randomized controlled trial at the ICU of the University Hospitals of Geneva (Switzerland). ICU patients eligible if they 18 yr old and had an AKI requiring CRRT Exclusion criteria Patients excluded if they had a...

see more →

News  61 results

A Practical and Cost-Effective Approach to the Diagnosis of Heparin-Induced Thrombocytopenia: A Single-Center Quality Improvement Study
https://www.mdedge.com/jcomjournal/article/252968/hospital-medicine/practical-and-cost-effective-approach-diagnosis-heparin
Alice Cusick, MD, Sarah Hanigan, PharmD et. al.

Mar 21st, 2022 - From the Veterans Affairs Ann Arbor Healthcare System Medicine Service (Dr. Cusick), University of Michigan College of Pharmacy, Clinical Pharmacy Service, Michigan Medicine (Dr.

Enoxaparin-Induced Hemorrhagic Bullae at Sites of Trauma and Endothelial Pathology
https://www.mdedge.com/dermatology/article/247860/wounds/enoxaparin-induced-hemorrhagic-bullae-sites-trauma-and-endothelial
Michael L. Garner, MD, Laura G. Pruitt, MD et. al.

Oct 25th, 2021 - To the Editor: A 67-year-old man with diabetes mellitus was admitted to the hospital for exacerbation of congestive heart failure and atrial flutter with rapid ventricular response. He subsequently developed a non-ST segment elevation myocardial i.

Organs From Deceased Recipients of AstraZeneca COVID-19 Vaccine May Pose Problems
https://www.medscape.com/viewarticle/955225

Jul 23rd, 2021 - NEW YORK (Reuters Health) - Organs from deceased donors who had received AstraZeneca's ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 may possibly prompt vaccine-induced thrombosis and thrombocytopenia (VITT) in recipients, according to a new study. A...

Thrombosis With Thrombocytopenia After mRNA COVID-19 Vaccine
https://www.medscape.com/viewarticle/953901

Jun 28th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. What is believed to be the first case of thrombosis with thrombocytopenia after a messenger RNA COVID-19 vaccine has been reported. The case repor...

Case Series Offers Solution for Post-COVID Vax Clotting?
https://www.medpagetoday.com/infectiousdisease/covid19vaccine/93017

Jun 9th, 2021 - Intravenous immune globulin (IVIG) helped resolve the effects of vaccine-induced thrombotic thrombocytopenia (VITT) in three patients following receipt of the AstraZeneca COVID-19 vaccine, a case series in Canada found. Following administration of...

see more →

Patient Education  1 results see all →